Cargando…
Fibulin-2 Facilitates Malignant Progression of Hepatocellular Carcinoma
BACKGROUND: Identification of biomarkers to assist in the clinical management of hepatocellular carcinoma represents an urgent requirement. Fibulin-2 is known to contribute to the development and progression of various cancer types. This research investigated the role of fibulin-2 in hepatocellular...
Autores principales: | Hu, Xinyan, Liu, Tianze, Li, Luting, Gan, Hairun, Wang, Tiancheng, Pang, Pengfei, Mao, Junjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Society of Gastroenterology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441129/ https://www.ncbi.nlm.nih.gov/pubmed/37162505 http://dx.doi.org/10.5152/tjg.2023.22134 |
Ejemplares similares
-
The NRF2-dependent transcriptional axis, XRCC5/hTERT drives tumor progression and 5-Fu insensitivity in hepatocellular carcinoma
por: Liu, Tianze, et al.
Publicado: (2021) -
DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA18
por: Gan, Hairun, et al.
Publicado: (2022) -
DDX24 promotes metastasis by regulating RPL5 in non‐small cell lung cancer
por: Hu, Xinyan, et al.
Publicado: (2022) -
Five novel RB1 gene mutations and genotype–phenotype correlations in Chinese children with retinoblastoma
por: Li, Luting, et al.
Publicado: (2022) -
Fibulin-2 Is a Driver of Malignant Progression in Lung Adenocarcinoma
por: Baird, Brandi N., et al.
Publicado: (2013)